Cleavage of periostin by MMP9 protects mice from kidney cystic disease - Des Maladies Rénales Rares aux Maladies Fréquentes, Remodelage et Réparation Accéder directement au contenu
Article Dans Une Revue PLoS ONE Année : 2023

Cleavage of periostin by MMP9 protects mice from kidney cystic disease

Résumé

The matrix metalloproteinase MMP9 influences cellular morphology and function, and plays important roles in organogenesis and disease. It exerts both protective and deleterious effects in renal pathology, depending upon its specific substrates. To explore new functions for MMP9 in kidney cysts formation and disease progression, we generated a mouse model by breeding juvenile cystic kidney (jck) mice with MMP9 deficient mice. Specifically, we provide evidence that MMP9 is overexpressed in cystic tissue where its enzymatic activity is increased 7-fold. MMP9 deficiency in cystic kidney worsen cystic kidney diseases by decreasing renal function, favoring cyst expansion and fibrosis. In addition, we find that periostin is a new critical substrate for MMP9 and in its absence periostin accumulates in cystic lining cells. As periostin promotes renal cyst growth and interstitial fibrosis in polycystic kidney diseases, we propose that the control of periostin by MMP9 and its associated intracellular signaling pathways including integrins, integrin-linked kinase and focal adhesion kinase confers to MMP9 a protective effect on the severity of the disease.
Fichier principal
Vignette du fichier
journal.pone.0294922.pdf (2.47 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-04329493 , version 1 (04-03-2024)

Identifiants

Citer

Nabila Djaziri, Cindy Burel, Lilia Abbad, Zeineb Bakey, Rémi Piedagnel, et al.. Cleavage of periostin by MMP9 protects mice from kidney cystic disease. PLoS ONE, 2023, 18 (12), pp.e0294922. ⟨10.1371/journal.pone.0294922⟩. ⟨hal-04329493⟩
33 Consultations
3 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More